![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/12/2897415/0/en/KSQ-Therapeutics-Announces-First-Patient-Dosed-in-Clinical-Development-Program-for-KSQ-001EX-a-CRISPR-Cas9-Engineered-Tumor-Infiltrating-Lymphocyte-eTIL-Therapy.html
https://www.fiercebiotech.com/biotech/roche-finds-usp-cancer-inking-deal-ksq-expand-stable-synthetic-lethal-candidates
https://www.fiercebiotech.com/biotech/takeda-puts-510m-line-expand-ksq-cancer-collaboration
https://www.businesswire.com/news/home/20230125005277/en/KSQ-Therapeutics-Announces-Ono-Pharmaceutical-Co.-Ltd.-is-Acquiring-Multiple-Research-Stage-Oncology-Programs-Identified-with-KSQ%E2%80%99s-CRISPRomics%C2%AE-Platform-Technology/?feedref=JjAwJuNHiystnCoBq_hl-R2sso4tCp8l0Yad2mB4_VJcgiwDl5F89IquLVWUqfRVgLxDkSKfgoruKb9yWl5as-PbWreMWuYBefATrZ0EPTVwBy5zzcjujtbJhwuWD3GRBSvR87oUDgbHejiywQBpbg==